Inhibition of human immunodeficiency virus type 1 infectivity by a new amine bellenamine

Antiviral Research

Volumn 29, Issue 2-3, 1996, Pages 163-173

  Ikeda, Ryuji ^a   Haraguchi, Yuji ^a   Ikeda, Yoko ^b   Kondo, Shinichi ^b   Takeuchi, Tomio ^b   Hoshino, Hiroo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b INSTITUTE OF MICROBIAL CHEMISTRY   (Japan)

Author keywords

antiviral agent; bellenamine; immunofluorescence assay; infectivity; plaque assay

Indexed keywords

1 DEOXYNOJIRIMYCIN; 1' N ACETYLBELLENAMINE; AMINE; ANTIVIRUS AGENT; BELLENAMINE; BETA LYSINAMIDE; CASTANOSPERMINE; CYCLIC BELLENAMINE; ENVELOPE PROTEIN; GAG PROTEIN; GLYCOSYLATION INHIBITING FACTOR; N AMINOMETHYLSUCCINAMIC ACID; NEW DRUG; PROTEINASE; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS ENZYME; VIRUS PROTEIN; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MANUFACTURE; DRUG MECHANISM; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOFLUORESCENCE; MOLECULAR WEIGHT; PRIORITY JOURNAL; STREPTOMYCES; T LYMPHOCYTE; VIRUS ADSORPTION; VIRUS INFECTIVITY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; STREPTOMYCES; STREPTOMYCES NASHVILLENSIS;

EID: 0029867413     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(95)00828-4     Document Type: Article

References (31)

1. Baba, M., Pauwels, R., Herdewijn, P., De Clercq, E., Desmyter, J. and Vandeputte, M. (1987) Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative (2′,3′-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro. Biochem. Biophys. Res. Commun. 142, 128-134.
2. Barré-Sinoussi, F., Chermann, J.C., Rey, F., Nugeyre, M.T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin. C., Vezinet-Brun, F., Rouzioux, C., Rozenbaum, W. and Montagnier, L. (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immunodeficiency syndrome (AIDS). Science 220, 868-871.
3. Chow, Y.K., Hirsch, M.S., Merrill, D.P., Bechtel, L.J., Eron, J.J., Kaplan, J.C. and D'Aquila, R.T. (1993) Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy. Nature 361, 650-654.
4. Dalgleish, A.G., Beverley, P.C.L., Clapham, P.R., Crawford, D.H., Greaves, M.F. and Weiss, R.A. (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312, 763-766.
5. De Clercq, E. (1995) Antiviral therapy for human immunodeficiency virus infections. Clin. Microb. Rev. 8, 200-239.
6. Fischl, M.A., Richman, D.D., Grieco, M.H., Gottlieb, M.S., Volberding, P.A., Laskin, O.L., Leedom, J.M., Groopman, J.E., Mildvan, D., Schooley, R.T., Jackson, G.G., Durack, D.T., King, D. and the AZT Collaborative Working Group (1987) The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N. Engl. J. Med. 317, 185-191.
7. Fitzgibbon, J.E., Howell, R.M., Haberzettl, C.A., Sperber, S.J., Gocke, D.J. and Dubin, D.T. (1992) Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2′,3′-dideoxycytidine. Antimicrob. Agents Chemother. 36, 153-157.
8. Gallo, R.C., Salahuddin, S.Z., Popovic, M., Shearer, G., Kaplan, M., Haynes, B.F., Palker, T.J., Redfield, R., Oleska, J., Safai, B., White, G., Foster, P. and Markham, P.D. (1984) Frequent detection and isolation of cytopathic retrovirus (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224, 500-503.
9. Gruters, R.A., Neefjes, J.J., Tersmette, M., de Goede, R.E.Y., Tulp, A., Huisman, H.G., Miedema, F. and Ploegh, H.L. (1987) Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Nature 330, 74-77.
10. Harada, S., Koyanagi, Y. and Yamamoto, N. (1985) Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229, 563-566.
11. Hoshino, H., Esumi, H., Miwa, M., Shimoyama, M., Minato, K., Tobinai, K., Hirose, M., Watanabe, S., Inada, N., Kinoshita, K., Kamihira, S., Ichimaru, M. and Sugimura, T. (1983) Establishment and characterization of 10 cell lines derived from patients with adult T-cell leukemia. Proc. Natl. Acad. Sci. USA 80, 6061-6065.
12. Ikeda, Y., Kondo, S., Ikeda, D., Yokose, K., Furutani, H., Ikeda, T., Hamada, M., Ishizuka, M., Takeuchi, T. and Umezawa, H. (1986) D-β-Lysylmethanediamine, a new biogenetic amine produced by a Streptomyces. J. Antibiot. 39, 476-478.
13. Ikeda, Y., Gomi, S., Hamada, M., Kondo, S. and Takeuchi, T. (1992a) Production of bellenamine and new metabolites in a synthetic medium. J. Antibiot. 45, 1763-1766.
14. Ikeda, Y., Ikeda, D. and Kondo, S. (1992b) Total syntheses of bellenamine and its isomers. J. Antibiot. 45, 1677-1680.
15. 15N labeled bellenamine and its degradation products. J. Antibiot. 45, 1925-1929.
16. Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J.-C. and Montagnier, L. (1984) T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312, 767-768.
17. Larder, B.A. and Kemp, S.D. (1989) Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science 246, 1155-1158.
18. Merigan, T.C., Skowron, G., Bozzette, S.A., Richman, D., Uttamchandani, R., Fischl, M., Schooley, R., Hirsch, M., Soo, W., Pettinelli, C., Schaumburg, H. and the ddC Study Group of the AIDS Clinical Trials Group (1989) Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections, a phase I and II study. Ann. Intl. Med. 110, 189-194.
19. Minowada, J., Ohnuma, T. and Moore, G.E. (1972) Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J. Natl. Cancer Inst. 49, 891-895.
20. Mitsuya, H. and Broder, S. (1986) Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2′,3′-dideoxynucleosides. Proc. Natl. Acad. Sci. USA 83, 1911-1915.
21. Mitsuya, H., Weinhold, K.J., Furman, P.A., St. Clair, M.H., Lehrman, S.N., Gallo, R.C., Bolognesi, D., Barry, D.W. and Broder, S. (1985) 3′-Azido-3′-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/ lymphadenopathy-associated virus in vitro. Proc. Natl. Acad. Sci. USA 82, 7096-7100.
22. Mitsuya, H., Yarchoan, R. and Broder, S. (1990) Molecular targets for AIDS therapy. Science 249, 1533-1544.
23. Miyoshi, I., Kubonishi, I., Yoshimoto, S., Akagi, T., Ohtsuki, Y., Shiraishi, Y., Nagata, K. and Hinuma, Y. (1981) Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 294, 770-771.
24. Montefiori, D.C., Robinson, W.E., Jr. and Mitchell, W.M. (1988) Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 85, 9248-9252.
25. Okamoto, T., Benter, T., Josephs, S.F., Sadaie, M.R. and Wong-Staal, F. (1990) Transcriptional activation from the long-terminal repeat of human immunodeficiency virus in vitro. Virology 177, 606-614.
26. Pauwels, R., Balzarini, J., Baba, M., Snoeck, R., Schols, D., Herdewijn, P., Desmyter, J. and De Clercq, E. (1988) Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 20, 309-321.
27. Popovic, M., Sarngadharan, M.G., Read, E. and Gallo, R.C. (1984) Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224, 497-500.
28. St. Clair, M.H., Martin, J.L., Tudor-Williams, G., Bach, M.C., Vavro, C.L., King, D.M., Kellam, P., Kemp, S.D. and Larder, B.A. (1991) Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. Science 253, 1557-1559.
29. Strebel, K., Daugherty, D., Clouse, K., Cohen, D., Folks, T. and Martin, M.A. (1987) The HIV 'A' (sor) gene product is essential for virus infectivity. Nature 328, 728-730.
30. Takeuchi, Y., Inagaki, M., Kobayashi, N. and Hoshino, H. (1987) Isolation of human immunodeficiency virus from a Japanese hemophilia B patient with AIDS. Jpn. J. Cancer Res. 78, 11-15.
31. Yarchoan, R., Mitsuya, H., Thomas, R.V., Pluda, J.M., Hartman, N.R., Perno, C.F., Marczyk, K.S., Allain, J.P., Johns, D.G. and Broder, S. (1989) In vivo activity against HIV and favorable toxicity profile of 2′,3′-dideoxyinosine. Science 245, 412-415.